TY - JOUR T1 - The Implementation, Diagnostic Yield and Clinical Outcome of Genetic Testing on an Inpatient Child and Adolescent Psychiatry Service JF - medRxiv DO - 10.1101/19004846 SP - 19004846 AU - Aaron D. Besterman AU - Joshua Sadik AU - Michael J. Enenbach AU - Fabiola Quintero-Rivera AU - UCLA Clinical Genomics Center AU - Mark DeAntonio AU - Julian A. Martinez-Agosto Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/09/14/19004846.abstract N2 - Objective Diagnostic genetic testing is recommended for children with neurodevelopmental disorders (NDDs). However, many children with NDDs do not receive genetic testing. One approach to improve access to genetic services for these patients is to offer testing on the inpatient child and adolescent psychiatry (CAP) service.Methods We implemented systematic genetic testing on an inpatient CAP service by providing medical genetics education to CAP fellows. We compared the genetic testing rates pre- and post-education. We compared the diagnostic yield to previously published studies and the demographics of our cohort to inpatients who received genetic testing on other clinical services. We assessed rates of outpatient genetics follow-up post-discharge.Results The genetic testing rate on the inpatient CAP service was 1.6% (2/125) before the educational intervention and 10.7% (21/197) afterwards (OR = 0.13, 95% CI = 0.015- 0.58, p = 0.0015). Diagnostic yield for patients on the inpatient service was 4.3% (1/23), lower than previously reported. However, 34.8% (8/23) of patients had variants of unknown significance (VUSs). 39.1% (9/23) of children who received genetic testing while inpatients were underrepresented minorities, compared to 7.7% (1/13) of patients who received genetic testing on other clinical services (OR = 7.35, CI = 0.81-365.00, p = 0.057). 43.5% of patients were lost to outpatient genetics follow-up.Conclusion Medical genetics education for fellows on an inpatient CAP service can improve genetic testing rates. Genetic testing for inpatients may primarily identify VUSs instead of well-known NDD risk variants. Genetic testing on the inpatient CAP service may improve access to genetic services for underrepresented minorities, but assuring outpatient follow-up can be challenging.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Aaron Besterman received funding support from the National Institutes of Health T32 UCLA Intercampus Medical Genetics Training Program (2T32GM008243-31). Mr. Joshua Sadik received funding support from the UCLA Medical Student Summer Research Fellowship Program in Psychiatry and Biobehavioral Sciences. Assistance with data extraction and preparation was provided by the UCLA Clinical Translational Sciences Institute (CTSI) Informatics Program, which was funded by the National Institutes of Health National Center for Advancing Translational Science CTSI Grant UL1TR001881.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesAll relevant data is included in the manuscript and supplement submitted. ER -